The inhibition of mGluR1 with the silencing of RNA was shown to reduce the viability, invasiveness, and migratory activities of human glioma cells (U87) in vitro, and reduced U87 tumor progression in vivo [88]. This evidence concerns the gene GRM1 and central nervous system cancer.